ENTRY       mmu00982                    Pathway
NAME        Drug metabolism - cytochrome P450 - Mus musculus (mouse)
CLASS       Metabolism; Xenobiotics biodegradation and metabolism
PATHWAY_MAP mmu00982  Drug metabolism - cytochrome P450
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        14261  Fmo1; flavin containing monooxygenase 1 [KO:K00485] [EC:1.14.13.8]
            14262  Fmo3; flavin containing monooxygenase 3 [KO:K00485] [EC:1.14.13.8]
            14263  Fmo5; flavin containing monooxygenase 5 [KO:K00485] [EC:1.14.13.8]
            55990  Fmo2; flavin containing monooxygenase 2 [KO:K00485] [EC:1.14.13.8]
            226564  Fmo4; flavin containing monooxygenase 4 [KO:K00485] [EC:1.14.13.8]
            226565  Fmo6; flavin containing monooxygenase 6 [KO:K00485] [EC:1.14.13.8]
            226601  Gm4846; predicted gene 4846 [KO:K00485] [EC:1.14.13.8]
            240894  Fmo9; flavin containing monooxygenase 9 [KO:K00485] [EC:1.14.13.8]
            226604  Gm4847; predicted gene 4847 [KO:K00485] [EC:1.14.13.8]
            14858  Gsta2; glutathione S-transferase, alpha 2 (Yc2) [KO:K00799] [EC:2.5.1.18]
            14859  Gsta3; glutathione S-transferase, alpha 3 [KO:K00799] [EC:2.5.1.18]
            14860  Gsta4; glutathione S-transferase, alpha 4 [KO:K00799] [EC:2.5.1.18]
            14862  Gstm1; glutathione S-transferase, mu 1 [KO:K00799] [EC:2.5.1.18]
            14863  Gstm2; glutathione S-transferase, mu 2 [KO:K00799] [EC:2.5.1.18]
            14866  Gstm5; glutathione S-transferase, mu 5 [KO:K00799] [EC:2.5.1.18]
            14867  Gstm6; glutathione S-transferase, mu 6 [KO:K00799] [EC:2.5.1.18]
            14870  Gstp1; glutathione S-transferase, pi 1 [KO:K00799] [EC:2.5.1.18]
            14871  Gstt1; glutathione S-transferase, theta 1 [KO:K00799] [EC:2.5.1.18]
            14872  Gstt2; glutathione S-transferase, theta 2 [KO:K00799] [EC:2.5.1.18]
            14873  Gsto1; glutathione S-transferase omega 1 [KO:K00799] [EC:2.5.1.18]
            14864  Gstm3; glutathione S-transferase, mu 3 [KO:K00799] [EC:2.5.1.18]
            66447  Mgst3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
            14857  Gsta1; glutathione S-transferase, alpha 1 (Ya) [KO:K00799] [EC:2.5.1.18]
            14869  Gstp2; glutathione S-transferase, pi 2 [KO:K00799] [EC:2.5.1.18]
            56615  Mgst1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
            68214  Gsto2; glutathione S-transferase omega 2 [KO:K00799] [EC:2.5.1.18]
            68312  Gstm7; glutathione S-transferase, mu 7 [KO:K00799] [EC:2.5.1.18]
            14865  Gstm4; glutathione S-transferase, mu 4 [KO:K00799] [EC:2.5.1.18]
            211666  Mgst2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
            103140  Gstt3; glutathione S-transferase, theta 3 [KO:K00799] [EC:2.5.1.18]
            75886  Gstt4; glutathione S-transferase, theta 4 [KO:K00799] [EC:2.5.1.18]
            76263  Gstk1; glutathione S-transferase kappa 1 [KO:K13299] [EC:2.5.1.18]
            54486  Hpgds; hematopoietic prostaglandin D synthase [KO:K04097] [EC:2.5.1.18 5.3.99.2]
            11522  Adh1; alcohol dehydrogenase 1 (class I) [KO:K13951] [EC:1.1.1.1]
            11529  Adh7; alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide [KO:K13951] [EC:1.1.1.1]
            26876  Adh4; alcohol dehydrogenase 4 (class II), pi polypeptide [KO:K13980] [EC:1.1.1.1]
            11532  Adh5; alcohol dehydrogenase 5 (class III), chi polypeptide [KO:K00121] [EC:1.1.1.1 1.1.1.284]
            11670  Aldh3a1; aldehyde dehydrogenase family 3, subfamily A1 [KO:K00129] [EC:1.2.1.5]
            56847  Aldh1a3; aldehyde dehydrogenase family 1, subfamily A3 [KO:K00129] [EC:1.2.1.5]
            67689  Aldh3b1; aldehyde dehydrogenase 3 family, member B1 [KO:K00129] [EC:1.2.1.5]
            621603  Aldh3b2; aldehyde dehydrogenase 3 family, member B2 [KO:K00129] [EC:1.2.1.5]
            73458  Aldh3b3; aldehyde dehydrogenase 3 family, member B3 [KO:K00129] [EC:1.2.1.5]
            17161  Maoa; monoamine oxidase A [KO:K00274] [EC:1.4.3.4]
            109731  Maob; monoamine oxidase B [KO:K00274] [EC:1.4.3.4]
            213043  Aox2; aldehyde oxidase 2 [KO:K00157] [EC:1.2.3.1]
            11761  Aox1; aldehyde oxidase 1 [KO:K00157] [EC:1.2.3.1]
            71872  Aox4; aldehyde oxidase 4 [KO:K00157] [EC:1.2.3.1]
            71724  Aox3; aldehyde oxidase 3 [KO:K00157] [EC:1.2.3.1]
            22238  Ugt2b5; UDP glucuronosyltransferase 2 family, polypeptide B5 [KO:K00699] [EC:2.4.1.17]
            22236  Ugt1a2; UDP glucuronosyltransferase 1 family, polypeptide A2 [KO:K00699] [EC:2.4.1.17]
            94284  Ugt1a6a; UDP glucuronosyltransferase 1 family, polypeptide A6A [KO:K00699] [EC:2.4.1.17]
            94215  Ugt2a1; UDP glucuronosyltransferase 2 family, polypeptide A1 [KO:K00699] [EC:2.4.1.17]
            394434  Ugt1a9; UDP glucuronosyltransferase 1 family, polypeptide A9 [KO:K00699] [EC:2.4.1.17]
            394430  Ugt1a10; UDP glycosyltransferase 1 family, polypeptide A10 [KO:K00699] [EC:2.4.1.17]
            394432  Ugt1a7c; UDP glucuronosyltransferase 1 family, polypeptide A7C [KO:K00699] [EC:2.4.1.17]
            394433  Ugt1a5; UDP glucuronosyltransferase 1 family, polypeptide A5 [KO:K00699] [EC:2.4.1.17]
            72094  Ugt2a3; UDP glucuronosyltransferase 2 family, polypeptide A3 [KO:K00699] [EC:2.4.1.17]
            552899  Ugt2a2; UDP glucuronosyltransferase 2 family, polypeptide A2 [KO:K00699] [EC:2.4.1.17]
            71773  Ugt2b1; UDP glucuronosyltransferase 2 family, polypeptide B1 [KO:K00699] [EC:2.4.1.17]
            394435  Ugt1a6b; UDP glucuronosyltransferase 1 family, polypeptide A6B [KO:K00699] [EC:2.4.1.17]
            394436  Ugt1a1; UDP glucuronosyltransferase 1 family, polypeptide A1 [KO:K00699] [EC:2.4.1.17]
            100727  Ugt2b34; UDP glucuronosyltransferase 2 family, polypeptide B34 [KO:K00699] [EC:2.4.1.17]
            231396  Ugt2b36; UDP glucuronosyltransferase 2 family, polypeptide B36 [KO:K00699] [EC:2.4.1.17]
            100559  Ugt2b38; UDP glucuronosyltransferase 2 family, polypeptide B38 [KO:K00699] [EC:2.4.1.17]
            112417  Ugt2b37; UDP glucuronosyltransferase 2 family, polypeptide B37 [KO:K00699] [EC:2.4.1.17]
            243085  Ugt2b35; UDP glucuronosyltransferase 2 family, polypeptide B35 [KO:K00699] [EC:2.4.1.17]
            13077  Cyp1a2; cytochrome P450, family 1, subfamily a, polypeptide 2 [KO:K07409] [EC:1.14.14.1]
            13106  Cyp2e1; cytochrome P450, family 2, subfamily e, polypeptide 1 [KO:K07415] [EC:1.14.13.-]
COMPOUND    C01471  Acrolein
            C01516  Morphine
            C05011  Hydroxytamoxifen
            C06174  Codeine
            C06754  Chloroacetaldehyde
            C06868  Carbamazepine
            C07047  Ifosfamide
            C07073  Lidocaine
            C07108  Tamoxifen
            C07163  Methadone
            C07185  Valproic acid
            C07492  Oxcarbazepine
            C07493  10-Hydroxycarbazepine
            C07495  Dihydroxycarbazepine
            C07496  Carbamazepine-10,11-epoxide
            C07501  Felbamate
            C07572  Citalopram
            C07643  4-Hydroxycyclophosphamide
            C07644  4-Ketocyclophosphamide
            C07645  Aldophosphamide
            C07646  Carboxyphosphamide
            C07647  Phosphoramide mustard
            C07888  Cyclophosphamide
            C08012  Levomethadyl acetate
            C11004  2,6-Dimethylaniline
            C11583  4-Glutathionyl cyclophosphamide
            C11785  Normorphine
            C16544  alpha-Hydroxytamoxifen
            C16545  Tamoxifen N-oxide
            C16546  N-Desmethyltamoxifen
            C16547  Endoxifen
            C16548  N,N-Didesmethyltamoxifen
            C16549  alpha-Hydroxy-N-desmethyltamoxifen
            C16550  Dechloroethylcyclophosphamide
            C16551  Alcophosphamide
            C16552  Nornitrogen mustard
            C16553  4-Hydroxyifosfamide
            C16554  4-Ketoifosfamide
            C16555  2-Dechloroethylifosfamide
            C16556  Aldoifosfamide
            C16557  Carboxyifosfamide
            C16558  Alcoifosfamide
            C16559  Isophosphoramide mustard
            C16560  3-Hydroxylidocaine
            C16561  Monoethylglycinexylidide
            C16569  Glycinexylidide
            C16570  4-Hydroxy-2,6-dimethylaniline
            C16571  2-Amino-3-methylbenzoate
            C16572  3-Hydroxymonoethylglycinexylidide
            C16576  Norcodeine
            C16577  Codeine-6-glucuronide
            C16578  Morphine-6-glucuronide
            C16582  2-Hydroxyfelbamate
            C16584  p-Hydroxyfelbamate
            C16586  2-Phenyl-1,3-propanediol monocarbamate
            C16587  3-Carbamoyl-2-phenylpropionaldehyde
            C16591  3-Carbamoyl-2-phenylpropionic acid
            C16592  Atropaldehyde
            C16595  4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one
            C16596  5-Phenyl-1,3-oxazinane-2,4-dione
            C16601  2-Hydroxycarbamazepine
            C16602  3-Hydroxycarbamazepine
            C16603  2,3-Dihydroxycarbamazepine
            C16604  2-Hydroxyiminostilbene
            C16605  2H-Dibenz[b,f]azepin-2-one
            C16606  Carbamazepine-o-quinone
            C16607  Citalopram N-oxide
            C16608  Demethylcitalopram
            C16609  Didemethylcitalopram
            C16610  Citalopram propionic acid
            C16612  Citalopram aldehyde
            C16643  Morphine-3-glucuronide
            C16648  2-n-Propyl-4-pentenoic acid
            C16649  4-Hydroxyvalproic acid
            C16650  5-Hydroxyvalproic acid
            C16651  3-Hydroxyvalproic acid
            C16652  3-Oxovalproic acid
            C16653  2-n-Propyl-2-pentenoic acid
            C16654  2-n-Propyl-3-pentenoic acid
            C16655  2-n-Propyl-4-oxopentanoic acid
            C16656  2-Propyl-2,4-pentadienoic acid
            C16657  2-Propylsuccinic acid
            C16658  2-Propylglutaric acid
            C16659  2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
            C16660  2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline
            C16661  L-alpha-Acetyl-N-normethadol
            C16662  L-alpha-Acetyl-N,N-dinormethadol
            D00195  Codeine (USP)
            D00252  Carbamazepine (JP17/USP/INN)
            D00343  Ifosfamide (JAN/USP/INN)
            D00358  Lidocaine (JP17/USP/INN)
            D00399  Valproic acid (USP)
            D00533  Oxcarbazepine (JAN/USAN/INN)
            D00536  Felbamate (USAN/INN)
            D04716  Levomethadyl acetate (USAN)
            D07704  Citalopram (USP/INN)
            D07760  Cyclophosphamide (INN)
            D08195  Methadone (BAN)
            D08233  Morphine (BAN)
            D08559  Tamoxifen (INN)
REFERENCE   
  AUTHORS   Kato R, Kamatari T (eds).
  TITLE     [Drug Metabolism] (In Japanese)
  JOURNAL   Tokyo Kagaku Dojin (2000)
REFERENCE   PMID:16038189
  AUTHORS   Gjerde J, Kisanga ER, Hauglid M, Holm PI, Mellgren G, Lien EA.
  TITLE     Identification and quantification of tamoxifen and four metabolites in serum by liquid chromatography-tandem mass spectrometry.
  JOURNAL   J Chromatogr A 1082:6-14 (2005)
            DOI:10.1016/j.chroma.2005.01.004
REFERENCE   PMID:18043895
  AUTHORS   Buck MB, Coller JK, Murdter TE, Eichelbaum M, Knabbe C.
  TITLE     TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells.
  JOURNAL   Breast Cancer Res Treat 107:15-24 (2008)
            DOI:10.1007/s10549-007-9526-7
REFERENCE   PMID:16550168
  AUTHORS   Rodriguez-Antona C, Ingelman-Sundberg M.
  TITLE     Cytochrome P450 pharmacogenetics and cancer.
  JOURNAL   Oncogene 25:1679-91 (2006)
            DOI:10.1038/sj.onc.1209377
REFERENCE   PMID:16393888
  AUTHORS   Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ.
  TITLE     Metabolism and transport of oxazaphosphorines and the clinical implications.
  JOURNAL   Drug Metab Rev 37:611-703 (2005)
            DOI:10.1080/03602530500364023
REFERENCE   PMID:11226815
  AUTHORS   Kosel M, Amey M, Aubert AC, Baumann P.
  TITLE     In vitro metabolism of citalopram by monoamine oxidase B in human blood.
  JOURNAL   Eur Neuropsychopharmacol 11:75-8 (2001)
            DOI:10.1016/S0924-977X(00)00128-0
REFERENCE   PMID:10575324
  AUTHORS   Olesen OV, Linnet K.
  TITLE     Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes.
  JOURNAL   Pharmacology 59:298-309 (1999)
            DOI:10.1159/000028333
REFERENCE   PMID:9698084
  AUTHORS   Rochat B, Kosel M, Boss G, Testa B, Gillet M, Baumann P.
  TITLE     Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver.
  JOURNAL   Biochem Pharmacol 56:15-23 (1998)
            DOI:10.1016/S0006-2952(98)00008-2
REFERENCE   
  AUTHORS   David AW, Thomas LL, William OF.
  TITLE     Foye's Principles of Medicinal Chemistry (5th ed)
  JOURNAL   Lippincott Williams & Wilkins (2002)
REFERENCE   PMID:11504799
  AUTHORS   Oda Y, Kharasch ED.
  TITLE     Metabolism of methadone and levo-alpha-acetylmethadol (LAAM) by human intestinal cytochrome P450 3A4 (CYP3A4): potential contribution of intestinal metabolism to presystemic clearance and bioactivation.
  JOURNAL   J Pharmacol Exp Ther 298:1021-32 (2001)
REFERENCE   PMID:10901707
  AUTHORS   Wang JS, Backman JT, Taavitsainen P, Neuvonen PJ, Kivisto KT.
  TITLE     Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans.
  JOURNAL   Drug Metab Dispos 28:959-65 (2000)
REFERENCE   PMID:12399158
  AUTHORS   Dieckhaus CM, Thompson CD, Roller SG, Macdonald TL.
  TITLE     Mechanisms of idiosyncratic drug reactions: the case of felbamate.
  JOURNAL   Chem Biol Interact 142:99-117 (2002)
            DOI:10.1016/S0009-2797(02)00057-1
REFERENCE   PMID:18463198
  AUTHORS   Pearce RE, Lu W, Wang Y, Uetrecht JP, Correia MA, Leeder JS
  TITLE     Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.
  JOURNAL   Drug Metab Dispos 36:1637-49 (2008)
            DOI:10.1124/dmd.107.019562
REFERENCE   PMID:12386121
  AUTHORS   Pearce RE, Vakkalagadda GR, Leeder JS.
  TITLE     Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.
  JOURNAL   Drug Metab Dispos 30:1170-9 (2002)
            DOI:10.1124/dmd.30.11.1170
REFERENCE   PMID:10859160
  AUTHORS   Kumar S, Wong H, Yeung SA, Riggs KW, Abbott FS, Rurak DW.
  TITLE     Disposition of valproic acid in maternal, fetal, and newborn sheep. II: metabolism and renal elimination.
  JOURNAL   Drug Metab Dispos 28:857-64 (2000)
REFERENCE   
  AUTHORS   Bernad T, Joachim M.
  TITLE     Hydrolysis in Drug and Prodrug Metabolism: Chemistry, Biochemistry, and Enzymology
  JOURNAL   Wiley-VCH (2003)
KO_PATHWAY  ko00982
///
